Monjuvi is a CD19-directed cytolytic antibody used in combination with lenalidomide to treat adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) not otherwise specified, including DLBCL arising from low grade lymphoma, and who are not eligible for autologous stem cell transplant (ASCT).
Recommended Dosage: The recommended dosage is 12 mg/kg as an intravenous infusion as per the following dosing schedule:
- Cycle 1: Days 1’st, 4’th, 8’th, 15’th and 22’nd of the 28-day cycle.
- Cycles 2 and 3: Days 1’st, 8’th, 15’th and 22’nd of each 28-day cycle.
- Cycle 4 and beyond: Days 1’st and 15’th of each 28-day cycle.
Administer Monjuvi in combination with lenalidomide for a maximum of 12 cycles and then continue this medicine as monotherapy until the disease is progressive or in case of unacceptable toxicity.
What documents are required to import MONJUVI to India?
MONJUVI (tafasitamab-cxix) can be imported by patients or government hospitals on the name of the patients only.
The following documentation required to import the product:
- Valid prescription from a qualified doctor.
- Patients diagnostic reports
- Patients id proof (issued by government of India)
How does order be confirmed?
The order will be confirmed only after the receipt of:
- Valid prescription of Doctor
- Import permit if applicable
Is MONJUVI available in India?
MONJUVI (Tafasitamab-cxix Injection) is a (prescription drug, prescription medication or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.
IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is facilitator providing input
- On availability in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore and Pune etc.)
- Medicine Price.
- Finding Genuine and reliable source from Canada, Europe, USA and AustraliaEnsuring 100% transparency.
MONJUVI (Tafasitamab-cxix 200 mg injection) can be made available to patients, doctors and hospitals at Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow and Pune and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and import permit.
IPN (Indian Pharma Network) can facilitate the supply of MONJUVI (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement (if applicable)
Please contact +91-9310090915 | Toll-Free No: 1800-889-1064 or write us at firstname.lastname@example.org for monjuvi price in India.
We take guarantee of quality and delivery anywhere in the world as per the buyer’s requirements.
Indian Pharma Network is able to source MONJUVI (Cancer Treatment Medicines) from across the globe, and has the ability to supply. Indian Pharma offers its customers worldwide access to the best available treatment.
Indian Pharma Network is able to dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.
What is the Generic Name for the trade name drug Monjuvi®?
Tafasitamab-cxix is Generic Name for the trade name drug Monjuvi®.
What is the Manufacturer Name of Monjuvi®?
Monjuvi® is manufactured by Morphosys US Inc.
Is Monjuvi® approved by the FDA?
Yes, Monjuvi® is approved by the FDA. Date of approval: July 31, 2020.
What is Monjuvi®?
It is a prescription medication given with lenalidomide to treat adult patients with certain types of diffuse large B-cell lymphoma (DLBCL) that has come back (relapsed) or that did not respond to previous treatment (refractory) and who are not eligible for stem cell transplant.
What is the dosage and form of Monjuvi® supplied?
Monjuvi is supplied for injection: 200 mg of tafasitamab-cxix as lyophilized powder in a single-dose vial for reconstitution.
What are the most common side effects due to Monjuvi®?
Most common side effects due to Monjuvi® include: decreased appetite, neutropenia, fatigue, anemia, cough, diarrhea, thrombocytopenia, pyrexia, peripheral edema, and respiratory tract infection.
What are the storage conditions of Monjuvi®?
Store refrigerated at 36-46°F (2-8°C) in the original carton in order to protect from light. Neither shake nor freeze it.
How much does Monjuvi® cost in India?
The monjuvi 200 mg cost in India is authentically less and competitive with other medications for DLBCL. In order to procure it, kindly connect to a WHO-GDP & ISO certified pharmaceutical Wholesaler/Distributor/Supplier.
What are the Highlights of prescribing information for Monjuvi®?